Avio Smart Market Stack Limited (ASMS) has taken another step in strengthening its Diagnostics and Healthcare business by initiating strategic discussions with Mediciti Institute of Medical Sciences (MIMS), Hyderabad, aimed at exploring opportunities for research collaboration, clinical validation and adoption of advanced molecular diagnostic technologies. The engagement forms part of ASMS’ broader strategy to build a scalable healthcare platform through partnerships that accelerate the development and deployment of innovative diagnostic solutions. The discussions involved clinicians, researchers, academic experts and industry leaders examining ways to enhance disease detection, improve clinical decision-making and expand access to advanced diagnostics across healthcare settings.
As part of the interaction, Huwel Lifesciences, ASMS’ strategic partner in molecular diagnostics, presented its portfolio of indigenous healthcare technologies. The company showcased diagnostic solutions covering a wide range of disease categories, including tuberculosis, multidrug-resistant tuberculosis, sepsis, human papillomavirus screening, hepatitis, antimicrobial resistance detection, respiratory illnesses and environmental surveillance.
The discussions focused on opportunities for collaborative research, product validation studies, evidence generation and potential deployment of these technologies within Mediciti’s healthcare ecosystem. The organizations also explored pilot projects and product evaluations designed to assess the effectiveness of advanced molecular diagnostics in real-world clinical environments.
Mediciti Institute of Medical Sciences was identified as a valuable partner due to its strong academic foundation, clinical expertise, patient outreach and research infrastructure. The institution’s capabilities are expected to support scientific evaluation and contribute to the broader adoption of innovative healthcare technologies.
Vidyasagar Reddy, Managing Director of Avio Smart Market Stack Limited, said the company remains committed to building a robust diagnostics business through strategic partnerships and market access initiatives. He emphasized that while scientific validation is essential, accelerating real-world adoption by healthcare institutions is equally important for delivering meaningful impact.
Dr Shesheer Kumar, Founder and Director of Huwel Lifesciences, highlighted the importance of collaboration between healthcare innovators, clinicians and research organizations in advancing diagnostic science. He noted that partnerships with institutions such as Mediciti can help validate emerging technologies and improve patient outcomes through evidence-based healthcare innovation.
The engagement reflects the growing role of indigenous healthcare technologies in addressing evolving public health challenges. It also underscores the importance of collaboration between industry and academia in bringing advanced diagnostic solutions to market.
Bartronics India Limited is a financial inclusion and rural fintech infrastructure company focused on expanding access to digital and assisted banking services across rural and semi-urban India. Through its corporate business correspondent network and technology-led operating model, the company supports public sector and regional rural banks in delivering secure and scalable financial services.
